FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gunhild Maelandsmo

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Physiology

Gene Expression Regulation, Neoplastic

Procedures

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
Ana Slipicevic; Geir Frode Øy; Øystein Stakkestad; Elisabeth Emilsen; Birgit Ø Engesaeter; Gunhild M Maelandsmo; Anne Katrine Ree Rosnes; Vivi Ann Flørenes
Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis.
Eldrid Borgan; Anne-Lise Børresen-Dale; Olav Engebraaten; Ingrid S Gribbestad; Evita M Lindholm; Ole Christian Lingjaerde; Gunhild M Maelandsmo; Siver Moestue; Therese Sørlie
Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts.
Mads H Haugen; HT Johansen; Klaudia Brix; Kjersti Flatmark; Solveig Pettersen; Rigmor Solberg; Gunhild M Maelandsmo
Nuclear legumain activity in colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gunhild Maelandsmo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ana Slipicevic; Geir Frode Øy; Øystein Stakkestad; Elisabeth Emilsen; Birgit Ø Engesaeter; Gunhild M Maelandsmo; Anne Katrine Ree Rosnes; Vivi Ann Flørenes
Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis.
Cancer biology & therapy 2013;14(2):146-54.
2013: Eldrid Borgan; Anne-Lise Børresen-Dale; Olav Engebraaten; Ingrid S Gribbestad; Evita M Lindholm; Ole Christian Lingjaerde; Gunhild M Maelandsmo; Siver Moestue; Therese Sørlie
Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts.
Molecular oncology 2013;7(1):130-42.
2013: Mads H Haugen; HT Johansen; Klaudia Brix; Kjersti Flatmark; Solveig Pettersen; Rigmor Solberg; Gunhild M Maelandsmo
Nuclear legumain activity in colorectal cancer.
PloS one 2013;8(1):e52980.
2012: Robert Smith; Magnus Abrahamson; Mads H Haugen; HT Johansen; Gunhild M Maelandsmo; Hilde Nilsen; Solveig Pettersen; Rigmor Solberg
Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M.
Biochimie 2012;94(12):2590-9.
2012: Evita M Lindholm; Gunhild M Maelandsmo; Hawa Nalwoga; Ståle Nygård; Lars A Akslen; Alexandr Kristian; Kristi Krüger; Olav Engebraaten
Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts.
Molecular oncology 2012;6(4):418-27.
2012: Christina Tekle; Yih-Wen Chen; Indrejit Dybsjord; Gunhild M Maelandsmo; Jahn Marthin Nesland; Marit Kveine Nygren; Oystein Fodstad
B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
International journal of cancer. Journal international du cancer 2012;130(10):2282-90.
2012: Else M Huuse; Kristi Krüger; Evita M Lindholm; Gunhild M Maelandsmo; Siver Moestue; Hawa Nalwoga; Lars A Akslen; Tone F Bathen; Anna M Bofin; Olav Engebraaten; Ingrid S Gribbestad
In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.
Journal of magnetic resonance imaging : JMRI 2012;35(5):1098-107.
2012: Pål Kristian Selbo; Anette Weyergang; Monica Bostad; Marius Strømbo Eng; Anders Høgset; Gunhild M Maelandsmo; Kristian Berg
Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug.
Journal of controlled release : official journal of the Controlled Release Society 2012;159(2):197-203.
2012: Birgit Ø Engesaeter; Vivi Ann Flørenes; Olav Engebraaten; Gunhild M Maelandsmo
Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
PloS one 2012;7(9):e45492.
2012: Stefan Kernstock; Gunhild M Maelandsmo; Anders Moen; Solveig Pettersen; Erna Davydova; Wolfgang Egge-Jacobsen; Magnus Jakobsson; Pål Ø Falnes
Lysine methylation of VCP by a member of a novel human protein methyltransferase family.
Nature communications 2012;3():1038.
2012: Ane Kongsgaard Rud; Steinar K Solberg; Gisle Berge; Odd T Brustugun; Marius Lund-Iversen; Gunhild M Maelandsmo; Kjetil Boye
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer.
BMC cancer 2012;12():333.
2012: Ana Slipicevic; Danny R Welch; Elisabeth Emilsen; Ruth Holm; Gunhild M Maelandsmo; Anne Katrine Ree Rosnes; Vivi Ann Flørenes
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.
BMC cancer 2012;12():73.
2011: Gisle Berge; Daniela Elena Costea; Marianne Berg; Ida Grotterød; Ragnhild A Lothe; Gunhild M Maelandsmo; Heidi Rasmussen; Kjersti Flatmark
Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma.
Amino acids 2011;41(4):875-84.
2011: Gisle Berge; Gunhild M Maelandsmo
Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53.
Amino acids 2011;41(4):863-73.
2011: Gisle Berge; Ingrid J Bettum; Kjetil Boye; Ida Grotterød; Solveig Pettersen; Gunhild M Maelandsmo
Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
International journal of cancer. Journal international du cancer 2011;129(4):780-90.
2011: Birgit O Engesaeter; Vivi Ann Flørenes; Tina Hellenes; Ruth Holm; Olav Engebråten; Menaka Sathermugathevan; Gunhild M Maelandsmo
Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells.
Cancer biology & therapy 2011;12(1):47-58.
2011: Kristin Andersen; Hidetoshi Mori; Jimmie E Fata; Jamie L Bascom; Tove Oyjord; Gunhild M Maelandsmo; Mina Bissell
The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis.
Developmental biology 2011;352(2):181-90.
2011: Elisabeth Paus; Mads Haugland Haugen; Kari Hauge Olsen; Kjersti Flatmark; Gunhild M Maelandsmo; Olle Nilsson; Eva Röijer; Maria Lundin; Christian Fermér; Maria Samsonova; Yuri Lebedin; Torgny Stigbrand
TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2011;32(1):1-12.
2010: Gisle Berge; Kristin Andersen; Mads H Haugen; Gunhild M Maelandsmo
Comment on the Importance of S100A4 in regulation of MMP-13.
The Journal of biological chemistry 2010;285(53):le23; author reply le24.
2010: Kjetil Boye; Jahn M Nesland; Berit Sandstad; Gunhild M Maelandsmo; Kjersti Flatmark
Nuclear S100A4 is a novel prognostic marker in colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2010;46(16):2919-25.
2010: Merete Thune Wiiger; Hege B Gehrken; Øystein Fodstad; Gunhild M Maelandsmo; Yvonne Andersson
A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth.
Cancer immunology, immunotherapy : CII 2010;59(11):1665-74.
2010: Ling Wang; Yang Jin; Yke Jildouw Arnoldussen; Ida Jonson; Su Qu; Gunhild M Maelandsmo; Alexandr Kristian; Bjørn Risberg; Håkon Waehre; Håvard E Danielsen; Fahri Saatcioglu
STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer.
Cancer research 2010;70(14):5818-28.
2010: Lina Prasmickaite; Nirma Skrbo; Hanne K Høifødt; Zhenhe Suo; Olav Engebråten; Hans P Gullestad; Steinar Aamdal; Øystein Fodstad; Gunhild M Maelandsmo
Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells.
Pigment cell & melanoma research 2010;23(3):449-51.
2010: Kjetil Boye; Gunhild M Maelandsmo
S100A4 and metastasis: a small actor playing many roles.
The American journal of pathology 2010;176(2):528-35.
2010: Geir Frode Oy; Ana Slipicevic; Ben Davidson; Ragnar Solberg Faye; Gunhild M Maelandsmo; Vivi Ann Flørenes
Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma.
International journal of cancer. Journal international du cancer 2010;126(2):350-61.
2010: Siver Moestue; Eldrid Borgan; Else M Huuse; Evita M Lindholm; Beathe Sitter; Anne-Lise Børresen-Dale; Olav Engebraaten; Gunhild M Maelandsmo; Ingrid S Gribbestad
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.
BMC cancer 2010;10():433.
2010: Ida Grotterød; Gunhild M Maelandsmo; Kjetil Boye
Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.
BMC cancer 2010;10():241.
2010: Lina Prasmickaite; Birgit Ø Engesaeter; Nirma Skrbo; Tina Hellenes; Alexandr Kristian; Nina K Oliver; Zhenhe Suo; Gunhild M Maelandsmo
Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma.
PloS one 2010;5(5):e10731.
2010: Mari Kaarbø; Oyvind Løveseter Mikkelsen; Lene Malerød; Su Qu; Viola H Lobert; Gulcan Akgul; Thomas Halvorsen; Gunhild M Maelandsmo; Fahri Saatcioglu
PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2010;32(1-2):11-27.
2010: Jon J Briggs; Mads H Haugen; HT Johansen; Adam I Riker; Magnus Abrahamson; Øystein Fodstad; Gunhild M Maelandsmo; Rigmor Solberg
Cystatin E/M suppresses legumain activity and invasion of human melanoma.
BMC cancer 2010;10():17.
2009: Anna Bergamaschi; Geir Olav Hjortland; Tiziana Triulzi; Therese Sørlie; Hilde Johnsen; Anne Hansen Ree; Hege Giercksky Russnes; Sigurd Tronnes; Gunhild M Maelandsmo; Oystein Fodstad; Anne-Lise Borresen-Dale; Olav Engebraaten
Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models.
Molecular oncology 2009;3(5-6):469-82.
2009: Renate Elenjord; Jasmine B Allen; Harald T Johansen; H Kildalsen; Gunbjørg Svineng; Gunhild M Maelandsmo; Thrina Loennechen; Jan-Olof Winberg
Collagen I regulates matrix metalloproteinase-2 activation in osteosarcoma cells independent of S100A4.
The FEBS journal 2009;276(18):5275-86.
2009: Jessica Cedervall; Seema Jamil; Lina Prasmickaite; YenFu Cheng; Malihe Eskandarpour; Johan Hansson; Gunhild M Maelandsmo; Ulrik Ringborg; Miklos Gulyas; He Suo Zhen; Lena Kanter; Lars Ahrlund-Richter
Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenografts.
Cancer research 2009;69(9):3746-54.
2009: Gunhild M Maelandsmo; Vivi Ann Flørenes; Mai T P Nguyen; Kjersti Flatmark; Ben Davidson
Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(1):15-25.
2008: Yke Jildouw Arnoldussen; Petra Isabel Lorenzo; Maria E Pretorius; Håkon Waehre; Björn Risberg; Gunhild M Maelandsmo; Håvard E Danielsen; Fahri Saatcioglu
The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
Cancer research 2008;68(22):9255-64.
2008: Kjetil Boye; Ida Grotterød; Hans-Christian Aasheim; Eivind Hovig; Gunhild M Maelandsmo
Activation of NF-kappaB by extracellular S100A4: analysis of signal transduction mechanisms and identification of target genes.
International journal of cancer. Journal international du cancer 2008;123(6):1301-10.
2008: Ragnar S Faye; Elisabeth Paus; Gunhild M Maelandsmo; Aasmund Berner; Hanne K Høifødt; Øystein Fodstad; Steinar Aamdal
S100B in bone marrow aspirates in healthy individuals and malignant melanoma patients.
Melanoma research 2008;18(2):134-40.
2007: Kristian Berg; Marco Folini; Lina Prasmickaite; Pål Kristian Selbo; Anette Bonsted; Birgit Ø Engesaeter; Nadia Zaffaroni; Anette Weyergang; Andreas Dietze; Gunhild M Maelandsmo; Ernst Wagner; Ole-Jacob Norum; Anders Høgset
Photochemical internalization: a new tool for drug delivery.
Current pharmaceutical biotechnology 2007;8(6):362-72.
2007: Teresa Cabezón; Julio E Celis; Inge Skibshøj; Jörg Klingelhöfer; Mariam Grigorian; Pavel Gromov; Fritz Rank; June H Myklebust; Gunhild M Maelandsmo; Eugene Lukanidin; Noona Ambartsumian
Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer.
International journal of cancer. Journal international du cancer 2007;121(7):1433-44.
2007: Trine Lillehammer; Birgit O Engesaeter; Lina Prasmickaite; Gunhild M Maelandsmo; Oystein Fodstad; Olav Engebraaten
Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
The journal of gene medicine 2007;9(6):440-51.
2007: Siri Tveito; Gunhild M Maelandsmo; Hanne K Hoifodt; Heidi Rasmussen; Oystein Fodstad
Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value.
Clinical & experimental metastasis 2007;24(5):317-27.
2007: Kjetil Boye; Kristin Andersen; Siri Tveito; Tove Øyjord; Gunhild M Maelandsmo
Interferon-gamma-induced suppression of S100A4 transcription is mediated by the class II transactivator.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(1):27-35.
2006: Birgit Ø Engesaeter; Anette Bonsted; Trine Lillehammer; Olav Engebraaten; Kristian Berg; Gunhild M Maelandsmo
Photochemically mediated delivery of AdhCMV-TRAIL augments the TRAIL-induced apoptosis in colorectal cancer cell lines.
Cancer biology & therapy 2006;5(11):1511-20.
2006: Birgit Ø Engesaeter; Siri Tveito; Anette Bonsted; Olav Engebraaten; Kristian Berg; Gunhild M Maelandsmo
Photochemical treatment with endosomally localized photosensitizers enhances the number of adenoviruses in the nucleus.
The journal of gene medicine 2006;8(6):707-18.
2006: Anette Bonsted; Birgit Ø Engesaeter; Anders Høgset; Gunhild M Maelandsmo; Lina Prasmickaite; Christine D'Oliveira; Wim E Hennink; Jan Hein van Steenis; Kristian Berg
Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor.
The journal of gene medicine 2006;8(3):286-97.
2005: Trine Lillehammer; Siri Tveito; Birgit O Engesaeter; Oystein Fodstad; Gunhild M Maelandsmo; Olav Engebraaten
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
Cancer gene therapy 2005;12(11):864-72.
2005: Kristin Bjørnland; Kjersti Flatmark; Solveig Pettersen; Ansgar O Aaasen; Oystein Fodstad; Gunhild M Maelandsmo
Matrix metalloproteinases participate in osteosarcoma invasion.
The Journal of surgical research 2005;127(2):151-6.
2005: Birgit Ø Engesaeter; Anette Bonsted; Kristian Berg; Anders Høgset; Olav Engebråten; Øystein Fodstad; David T Curiel; Gunhild M Maelandsmo
PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles.
Cancer gene therapy 2005;12(5):439-48.
2005: Gunhild M Maelandsmo; P Joel Ross; Marta Pavliv; Robert A Meulenbroek; Carole Evelegh; Daniel A Muruve; Frank L Graham; Robin J Parks
Use of a murine secreted alkaline phosphatase as a non-immunogenic reporter gene in mice.
The journal of gene medicine 2005;7(3):307-15.
2004: Vivi Ann Flørenes; Gunhild M Maelandsmo; Ruth Holm; Reuven Reich; Philip Lazarovici; Ben Davidson
Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome.
American journal of clinical pathology 2004;122(3):412-20.
2004: Kjetil Boye Pedersen; Kristin Andersen; Øystein Fodstad; Gunhild M Maelandsmo
Sensitization of interferon-gamma induced apoptosis in human osteosarcoma cells by extracellular S100A4.
BMC cancer 2004;4():52.
2004: Kristin Andersen; Jahn M Nesland; Ruth Holm; Vivi Ann Flørenes; Øystein Fodstad; Gunhild M Maelandsmo
Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(8):990-7.
2004: Kjersti Flatmark; Gunhild M Maelandsmo; Marita Martinsen; Heidi Rasmussen; Øystein Fodstad
Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice.
European journal of cancer (Oxford, England : 1990) 2004;40(10):1593-8.
2004: Daniel A Muruve; Matthew J Cotter; Anne K Zaiss; Lindsay R White; Qiang Liu; Trevor Chan; Sharon A Clark; P Joel Ross; Robert A Meulenbroek; Gunhild M Maelandsmo; Robin J Parks
Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
Journal of virology 2004;78(11):5966-72.
2004: Skjalg Bruheim; Oyvind S Bruland; Knut Breistol; Gunhild M Maelandsmo; Oystein Fodstad
Human osteosarcoma xenografts and their sensitivity to chemotherapy.
Pathology oncology research : POR 2004;10(3):133-41.
2004: Kjersti Flatmark; Gunhild M Maelandsmo; Svein-Ole Mikalsen; Kjell Nustad; Tone Varaas; Heidi Rasmussen; Gunn Iren Meling; Øystein Fodstad; Elisabeth Paus
Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(1-2):31-40.
2004: Anette Bonsted; Birgit Ø Engesaeter; Anders Høgset; Gunhild M Maelandsmo; Lina Prasmickaite; Olav Kaalhus; Kristian Berg
Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses.
Gene therapy 2004;11(2):152-60.
2003: Thrina Loennechen; Berit Mathisen; Janne Hansen; Rune I Lindstad; Sara Ann El-Gewely; Kristin Andersen; Gunhild M Maelandsmo; Jan-Olof Winberg
Colchicine induces membrane-associated activation of matrix metalloproteinase-2 in osteosarcoma cells in an S100A4-independent manner.
Biochemical pharmacology 2003;66(12):2341-53.
2003: Kjersti Jørgensen; Ruth Holm; Gunhild M Maelandsmo; Vivi Ann Flørenes
Expression of activated extracellular signal-regulated kinases 1/2 in malignant melanomas: relationship with clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5325-31.
2003: Gunhild M Maelandsmo; Ruth Holm; Jahn M Nesland; Øystein Fodstad; Vivi Ann Flørenes
Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3383-8.
2003: Jørn Henriksen; Trude H Aagesen; Gunhild M Maelandsmo; Ragnhild A Lothe; Ola Myklebost; Anne Forus
Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation.
Oncogene 2003;22(34):5358-61.
2003: Kjersti Flatmark; Kjetil Boye Pedersen; Jahn M Nesland; Heidi Rasmussen; Geir Aamodt; Svein-Ole Mikalsen; Kristin Bjørnland; Øystein Fodstad; Gunhild M Maelandsmo
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer.
The Journal of pathology 2003;200(5):589-95.
2003: Kristin Andersen; Birgitte Smith-Sørensen; Kjetil Boye Pedersen; Eivind Hovig; Ola Myklebost; Øystein Fodstad; Gunhild M Maelandsmo
Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest.
British journal of cancer 2003;88(12):1995-2001.
2003: Anders Høgset; Lina Prasmickaite; Birgit O Engesaeter; Marit Hellum; Pål Kristian Selbo; Vibeke Murberg Olsen; Gunhild M Maelandsmo; Kristian Berg
Light directed gene transfer by photochemical internalisation.
Current gene therapy 2003;3(2):89-112.
2003: Berit Mathisen; Rune I Lindstad; Janne Hansen; Sara Ann El-Gewely; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells.
Clinical & experimental metastasis 2003;20(8):701-11.
2003: Ase Bratland; Erlend Ragnhildstveit; Kristin Bjørnland; Kristin Andersen; Gunhild M Maelandsmo; Oystein Fodstad; Fahri Saatcioglu; Anne Hansen Ree
The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.
Clinical & experimental metastasis 2003;20(6):541-7.
2002: Kjetil Boye Pedersen; Jahn M Nesland; Øystein Fodstad; Gunhild M Maelandsmo
Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies.
British journal of cancer 2002;87(11):1281-6.
2002: Anne Hansen Ree; Ase Bratland; Roger Kroes; Hans-Christian Aasheim; Vivi Ann Flørenes; Joseph R Moskal; Oystein Fodstad; Oyvind S Bruland; Gunhild M Maelandsmo
Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases.
Anticancer research 2002;22(4):1949-57.
2002: Anders Høgset; Birgit O Engesaeter; Lina Prasmickaite; Kristian Berg; Oystein Fodstad; Gunhild M Maelandsmo
Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy.
Cancer gene therapy 2002;9(4):365-71.
2002: Leonardo A. Meza-Zepeda; Anne Forus; Birgitte Lygren; Anine B Dahlberg; Linda H Godager; Andrew P South; Ingo Marenholz; Maria Lioumi; Vivi Ann Flørenes; Gunhild M Maelandsmo; Massimo Serra; Dietmar Mischke; Dean Nizetic; Jiannis Ragoussis; Maija Tarkkanen; Jahn M Nesland; Sakari Knuutila; Ola Myklebost
Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21.
Oncogene 2002;21(14):2261-9.
2001: Vivi Ann Flørenes; Gunhild M Maelandsmo; Ragnar S Faye; Jahn M Nesland; Ruth Holm
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
The Journal of pathology 2001;195(5):530-6.
2001: Anne Forus; Anna D'Angelo; Jørn Henriksen; Giuseppe Merla; Gunhild M Maelandsmo; Vivi Ann Flørenes; Stefano Olivieri; Bodil Bjerkehagen; Leonardo A. Meza-Zepeda; F del Vecchio Blanco; C Müller; Francesca Sanvito; J Kononen; Jahn M Nesland; Øystein Fodstad; Alexandre Reymond; Olli Kallioniemi; Gianluigi Arrigoni; Andrea Ballabio; Ola Myklebost; Massimo Zollo
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity.
Oncogene 2001;20(47):6881-90.
2001: Kristin Bjørnland; E Rugnes; Solveig Pettersen; HT Johansen; Ansgar O Aasen; Øystein Fodstad; Anne Hansen Ree; Gunhild M Maelandsmo
Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells.
Journal of pediatric surgery 2001;36(7):1040-4.
2001: Eivind Hovig; Gunhild M Maelandsmo; T Mellingsaeter; Oystein Fodstad; S S Mielewczyk; J Wolfe; J Goodchild
Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA.
Antisense & nucleic acid drug development 2001;11(2):67-75.
2000: Ase Bratland; Karianne Risberg; Gunhild M Maelandsmo; Kristine Bjerve Gützkow; O E Olsen; A Moghaddam; M Y Wang; C M Hansen; Heidi Kiil Blomhoff; Jens Berg; Oystein Fodstad; Anne Hansen Ree
Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells.
Cancer research 2000;60(19):5578-83.
2000: Vivi Ann Flørenes; Ragnar S Faye; Gunhild M Maelandsmo; Jahn M Nesland; Ruth Holm
Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3614-20.
2000: Alexander Fosså; R Siebert; Hans-Christian Aasheim; Gunhild M Maelandsmo; Aasmund Berner; Sophie D Fosså; Elisabeth Paus; Erlend Smeland; Gustav Gaudernack
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer.
British journal of cancer 2000;83(6):743-9.
1999: Kristin Bjørnland; Jan-Olof Winberg; O T Odegaard; Eivind Hovig; Thrina Loennechen; Ansgar O Aasen; Oystein Fodstad; Gunhild M Maelandsmo
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Cancer research 1999;59(18):4702-8.
1998: Lina Prasmickaite; A Hogset; Gunhild M Maelandsmo; Kristian Berg; J Goodchild; T Perkins; Oystein Fodstad; Eivind Hovig
Intracellular metabolism of a 2'-O-methyl-stabilized ribozyme after uptake by DOTAP transfection or asfree ribozyme. A study by capillary electrophoresis.
Nucleic acids research 1998;26(18):4241-8.
1998: K Andersen; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL.
Anticancer research 1998;18(5A):3299-303.
1998: OK Hjelstuen; Gunhild M Maelandsmo; H Hjorth Tønnesen; P O Bremmer; AM Verbruggen
Hybridization of a 99Tcm-labelled oligodeoxynucleotide to CAPL RNA.
Nuclear medicine communications 1998;19(8):803-12.
1998: Vivi Ann Flørenes; Gunhild M Maelandsmo; Robert S Kerbel; Joyce M Slingerland; J M Nesland; R Holm
Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival.
The American journal of pathology 1998;153(1):305-12.
1997: Anne Hansen Ree; V A Florenes; Jens Berg; Gunhild M Maelandsmo; J M Nesland; Oystein Fodstad
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1623-8.
1997: Gunhild M Maelandsmo; Vivi Ann Flørenes; T Mellingsaeter; Eivind Hovig; R S Kerbel; Oystein Fodstad
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma.
International journal of cancer. Journal international du cancer 1997;74(4):464-9.
1997: H de Graaf; Gunhild M Maelandsmo; P Ruud; Anne Forus; T Oyjord; Oystein Fodstad; Eivind Hovig
Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2.
International journal of cancer. Journal international du cancer 1997;72(1):191-6.
1996: Gunhild M Maelandsmo; Eivind Hovig; Martina Skrede; Olav Engebraaten; Vivi Ann Flørenes; Ola Myklebost; Mariam Grigorian; Eugene Lukanidin; K J Scanlon; Oystein Fodstad
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.
Cancer research 1996;56(23):5490-8.
1996: Gunhild M Maelandsmo; Ruth Holm; Oystein Fodstad; Robert S Kerbel; Vivi Ann Flørenes
Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions.
The American journal of pathology 1996;149(6):1813-22.
1996: Anne Hansen Ree; Gunhild M Maelandsmo; Oystein Fodstad
Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression.
Clinical & experimental metastasis 1996;14(4):381-8.
1996: Gunhild M Maelandsmo; Vivi Ann Flørenes; Eivind Hovig; T Oyjord; Olav Engebraaten; Ruth Holm; A L Børresen; Oystein Fodstad
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
British journal of cancer 1996;73(8):909-16.
1995: Gunhild M Maelandsmo; Jeanne-Marie Berner; Vivi Ann Flørenes; Anne Forus; Eivind Hovig; Oystein Fodstad; Ola Myklebost
Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
British journal of cancer 1995;72(2):393-8.
1994: Anne Forus; Vivi Ann Flørenes; Gunhild M Maelandsmo; Oystein Fodstad; Ola Myklebost
The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas.
Cancer genetics and cytogenetics 1994;78(2):165-71.
1994: Vivi Ann Flørenes; Gunhild M Maelandsmo; Anne Forus; A Andreassen; Ola Myklebost; Oystein Fodstad
MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
Journal of the National Cancer Institute 1994;86(17):1297-302.
1993: Anne Forus; Vivi Ann Flørenes; Gunhild M Maelandsmo; Paul S Meltzer; Oystein Fodstad; Ola Myklebost
Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(12):1065-70.
1992: Vivi Ann Flørenes; Steinar Aamdal; Ola Myklebost; Gunhild M Maelandsmo; Oyvind S Bruland; Oystein Fodstad
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.
Cancer research 1992;52(21):6088-91.
1992: Marit S Nenseter; O Gudmundsen; N Roos; Gunhild M Maelandsmo; Christian Andre Drevon; T Berg
Role of liver endothelial and Kupffer cells in clearing low density lipoprotein from blood in hypercholesterolemic rabbits.
Journal of lipid research 1992;33(6):867-77.
1992: B Skrede; Rune Blomhoff; Gunhild M Maelandsmo; L Ose; Ola Myklebost; Kaare R Norum
Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo.
European journal of clinical investigation 1992;22(4):229-34.
1992: Marit S Nenseter; Arild C Rustan; S Lund-Katz; E Søyland; Gunhild M Maelandsmo; M C Phillips; Christian Andre Drevon
Effect of dietary supplementation with n-3 polyunsaturated fatty acids on physical properties and metabolism of low density lipoprotein in humans.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(3):369-79.
1989: Gunhild M Maelandsmo; Anne Carine Ostvold; S G Laland
Phosphorylation of the high-mobility-group-like protein P1 by casein kinase-2.
European journal of biochemistry / FEBS 1989;184(3):529-34.